Clinical Trial Update: Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 study of vinblastine plus carboplatin in children with newly diagnosed or recurrent low-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Neurofibromatosis Type

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Vinblastine (vinblastine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain and Central Nervous System Tumors, Neurofibromatosis Type 1 | Phase 1 | Status: COMPLETED